One Third of Japanese Patients with Multiple Osteochondromas May Have Mutations in Genes Other Than EXT1 or EXT2
| Autor: | Hiroshi Seki, Yoshimitsu Fukushima, Takahito Wada, Takeo Kubota, Keiko Wakui, Hirofumi Kojima |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Genetics
Multiple osteochondroma Hereditary multiple exostoses DNA Mutational Analysis Disease Biology N-Acetylglucosaminyltransferases medicine.disease Polymerase Chain Reaction Asian People Japan Mutation medicine Humans Polymorphism analysis Gene Chromatography High Pressure Liquid Exostoses Multiple Hereditary Genetics (clinical) |
| Zdroj: | Genetic Testing. 12:557-561 |
| ISSN: | 1557-7473 1090-6576 |
| DOI: | 10.1089/gte.2008.0048 |
| Popis: | Multiple osteochondromas (MO; also referred to as hereditary multiple exostoses [HME] in the literature) is an autosomal dominant disorder characterized by benign, cartilage-capped bone tumors that grow from the metaphyses of long bones. Two genes are associated with this disease: EXT1 on 8q24.11-q24.13 and EXT2 on 11p12-p11. Mutations in EXT1 and EXT2 are found in 54-96% of patients with MO and are generally more frequent in EXT1 than in EXT2. We previously studied 43 Japanese families with MO using single-strand conformation polymorphism analysis for EXT1 and EXT2, and reported 23 families (54%) with mutations and 20 families (46%) with no mutations in these genes. Among the families with mutations, 17 families (40%) had mutations in EXT1, and 6 families (14%) had mutations in EXT2. Here we examined the same 43 Japanese families using denaturing high-performance liquid chromatography as an alternative technique. We detected five mutations, three of which are novel, in seven families in addition to the previously described mutations. In summary, we detected mutations in EXT1 or EXT2 in 30 (70%) out of 43 families. Our result suggests the presence of other gene(s) responsible for MO, at least in Japanese patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|